Bangladesh Secondary Transmission Handwashing Protocol
NCT00880659 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6600
Last updated 2010-12-30
Summary
The next influenza pandemic is expected to spread rapidly in resource-poor settings. Influenza viruses spread from human-to-human via large respiratory droplets. Transmission via large-particle respiratory droplets is believed to be mediated by close contact between infected and susceptible persons or contact with droplet-contaminated fomites. Close contact between infected and susceptible persons may consist of skin-to-skin contact (e.g., via hands) or inhalation of respiratory droplets (e.g., due to talking, coughing, or sneezing by the infected person). Airborne transmission, which is expected to result in transmission over long distances (\>1 meter) and which would be mediated by ventilation, is believed to be uncommon. Therefore, the greatest risk of transmission from personal contact comes from those people who are closest to an index case, such as contacts living in the same household. There are, to date, no published estimates of the secondary attack ratio of influenza among household contacts of index case-patients in low-income countries. Moreover, the investigators do not have data on the risk factors for secondary transmission of influenza from index case-patients to their household contacts. There is some data for the benefits of promoting handwashing with soap on the risk of all-cause acute respiratory illness among children \< 15 years old in a resource-poor setting in Pakistan. But, the investigators do not have evidence that promoting handwashing with soap will acutely reduce the risk of secondary transmission. Therefore, the investigators propose to conduct a study in rural Bangladesh to assess the following:
* The secondary attack ratio of influenza among household contacts of an index case-patient with influenza
* The risk factors for secondary transmission of influenza from an index case-patient to household contacts
* The impact of promoting handwashing with soap on the risk of secondary transmission of influenza from an index case-patient to household contacts
* The impact of handwashing promotion on handwashing behavior six months after intervention
* The impact of handwashing promotion on the prevalence of respiratory infections, diarrhea and influenza
Conditions
- Human Influenza
Interventions
- BEHAVIORAL
-
Soap
Promotion of handwashing with soap
Sponsors & Collaborators
-
State University of New York at Buffalo
collaborator OTHER -
International Centre for Diarrhoeal Disease Research, Bangladesh
lead OTHER
Principal Investigators
-
Eduardo Azziz-Baumgartner, MD, MPH · International Centre for Diarrhoeal Disease Research, Bangladesh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2010-10-31
- Completion
- 2010-12-31
Countries
- Bangladesh
Study Locations
More Related Trials
-
Evaluating Modes of Influenza Transmission
NCT01710111 ·Status: COMPLETED ·Phase: NA
-
Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission
NCT00490633 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
NCT05027932 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Performance of the Diassess Influenza A and B Test
NCT03035396 ·Status: COMPLETED ·Phase: NA
-
REDucing Influenza Among University Students, University of California at Berkeley
NCT00448773 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine Uptake Among Healthcare Workers
NCT05521763 ·Status: UNKNOWN ·Phase: NA
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older
NCT00975572 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults
NCT02350751 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Exclusion Criteria in a University Population
NCT01472536 ·Status: COMPLETED ·Phase: NA
-
An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh
NCT04998344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China
NCT00760500 ·Status: COMPLETED
-
Rapid Diagnostic Test for Influenza
NCT01089816 ·Status: COMPLETED
-
Evaluating Modes of Influenza Transmission 2b Baseline SAR
NCT07342556 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults
NCT01258842 ·Status: UNKNOWN ·Phase: PHASE3
-
2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control Strategies
NCT01270685 ·Status: WITHDRAWN
-
Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain
NCT02423577 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza
NCT01037205 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Validation of the Point-of-Care MSD Influenza Test
NCT00863343 ·Status: TERMINATED
-
Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers
NCT04223544 ·Status: UNKNOWN
-
Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine
NCT03028116 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents
NCT02352389 ·Status: COMPLETED
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs
NCT02124096 ·Status: COMPLETED
-
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
NCT00800605 ·Status: COMPLETED ·Phase: PHASE3
-
Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting
NCT02478905 ·Status: COMPLETED